Oprozomib
Oprozomib (ONX-0912; PR-047) is a potent, orally bioavailable proteasome inhibitor that inhibits chymotrypsin-like (CT-L) activity of 20S proteasome β5/LMP7 with IC50 of 36/82 nM.
Product Specifications
CAS Number
935888-69-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
532.6092
Molecular Formula
C25H32N4O7S
Notes
Research use only, not for human use.
Receptor
20Sproteasome
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2435002 1.0 µg DNA
TRAJ13 sgRNA CRISPR Lentivector (Human) (Target 1)
Sign In for Pricing
View Details 
bs-0319R-PerCP 100 µL
E1 glycoprotein Polyclonal Antibody, PerCP Conjugated
Sign In for Pricing
View Details